Newsroom

LONDON--(BUSINESS WIRE)--Convatec, ein führendes Unternehmen für medizinische Produkte und Technologien mit Schwerpunkt auf der Behandlung chronischer Erkrankungen, wird auf der Konferenz der European Wound Management Association (EWMA) 2026 vom 6. bis 8. Mai 2026 in Bremen die Breite, Tiefe und Dynamik seiner Innovationspipeline im Bereich der modernen Wundversorgung präsentieren. Die branchenführende Innovation von Convatec im Bereich der fortschrittlichen Wundversorgung wird durch überzeugen...

LONDRES--(BUSINESS WIRE)--Convatec, une entreprise de premier plan spécialisée dans les produits et technologies médicaux destinés à la prise en charge des maladies chroniques, se mettra en avant pour présenter l'étendue, la richesse et la dynamique de son portefeuille d'innovations dans le domaine des soins avancés des plaies lors du congrès 2026 de l'Association européenne de gestion des plaies (EWMA), qui se tiendra à Brême, en Allemagne, du 6 au 8 mai 2026. L'innovation de pointe de Convate...

LONDRES--(BUSINESS WIRE)--Convatec, empresa líder en productos y tecnologías médicas especializada en el tratamiento de enfermedades crónicas, participará en el congreso de la European Wound Management Association (EWMA) 2026, que se celebrará en Bremen (Alemania) del 6 al 8 de mayo de 2026. En este contexto, la empresa pondrá de relieve la amplitud, la solidez y el dinamismo de su cartera de innovación en tratamiento avanzado de heridas. El comunicado en el idioma original es la versión oficia...

LONDRA--(BUSINESS WIRE)--Convatec, azienda leader di prodotti e tecnologia in ambito medico orientata alla gestione di patologie croniche, salirà sul palco per evidenziare la profondità, l'ampiezza e lo slancio della sua pipeline di innovazione nel campo della cura avanzata delle ferite in occasione della conferenza 2026 della European Wound Management Association (EWMA) in corso a Brema, Germania, dal 6 all'8 maggio 2026. Il testo originale del presente annuncio, redatto nella lingua di parten...

LONDEN--(BUSINESS WIRE)--Convatec, een vooraanstaand bedrijf gespecialiseerd in medische producten en technologie gericht op beheer van chronische condities, komt op de voorgrond met een demonstratie van de breedte, de diepte en het momentum achter zijn Advanced Wound Care-innovatiepijplijn tijdens de EWMA (European Wound Management Association) 2026 conferentie in Bremen, Duitsland, die doorgaat van 6 tot 8 mei 2026. Deze bekendmaking is officieel geldend in de originele brontaal. Vertalingen...

LONDON--(BUSINESS WIRE)--  ISIN Code. XS3148222857 Our Ref. MT9931 ISSUE NAME. Commonwealth Bank of Australia Issue of GBP 250,000,000.00 Floating Rate Notes due August 202 Series 6685 Tranche 1 mtn INTEREST PERIOD. 12/02/2026 TO 12/05/2026 VALUE DATE. 12/05/2026 INTEREST RATE. 4.08548 PCT NUM OF DAYS. 89 DAY BASIS. ACTUAL/365 FIXED (A005) CURRENCY CODE. GBP TOTAL INTEREST AMT. GBP 2,490,463.84 POOL FACTOR. N/A...

ZUG, Switzerland--(BUSINESS WIRE)--AMINA Bank AG ("AMINA"), a Swiss Financial Market Supervisory Authority (FINMA)-regulated crypto bank with global reach, today becomes the first bank to support Canton Coin (CC), the native token of Canton Network, offering custody and trading services to its clients. Canton Network is a public, privacy-preserving blockchain built for capital markets. Canton has gained significant institutional momentum in recent months, attracting TradFi and DeFi organization...

BERLIN & SAN FRANCISCO--(BUSINESS WIRE)--Bayer and Perfuse Therapeutics Inc. today announced an agreement under which Bayer will fully acquire Perfuse Therapeutics, a biopharmaceutical company pioneering transformational research into the treatment of ischemia-induced ocular diseases. With this acquisition, Bayer will hold the full rights pertaining to PER-001, a small molecule endothelin receptor antagonist currently in Phase II clinical development for the treatment of Glaucoma and Diabetic R...

STAMFORD, Conn.--(BUSINESS WIRE)--ClearDox rebrands to ClearOpx and introduces the industry's first Operations Trade Risk Management (OTRM) Platform....

STOCKHOLM--(BUSINESS WIRE)--EvoluteIQ announced the appointment of Paul Maguire as Chief Growth Officer and Abhinaya S R as Chief Human Resources Officer...